ACRX

Q: What is the price of AcelRx Pharmaceuticals (ACRX) today?

The price of AcelRx Pharmaceuticals (ACRX) today is $ 0.00, with return of 0% compared to the last year. The price of AcelRx Pharmaceuticals (ACRX) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of AcelRx Pharmaceuticals (ACRX) and international markets.

Q: When does AcelRx Pharmaceuticals (ACRX) pay dividends?

AcelRx Pharmaceuticals (ACRX) did not distribute dividends in the last year.

Q: Is AcelRx Pharmaceuticals (ACRX) worth it?

Currently, AcelRx Pharmaceuticals (ACRX) is priced at $ 0.00, with a P/E of 0.61%, representing a deviation of -1,242% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy AcelRx Pharmaceuticals (ACRX) stock?

Investing in stocks of AcelRx Pharmaceuticals (ACRX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of AcelRx Pharmaceuticals (ACRX) yield today?

The yield of AcelRx Pharmaceuticals (ACRX) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of AcelRx Pharmaceuticals (ACRX) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AcelRx Pharmaceuticals Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

0.61

p/bv

1.35

DIVIDEND YIELD

0.00%

price ACRX

ACRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ACRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ACRX

review the fundamentals of AcelRx Pharmaceuticals shares

P/E

0.61

Sector: -2.13 Industry: 12.28

P/SALES RATIO (PSR)

15.08

Sector: 2.09 Industry: 3.41

P/BV

1.35

Sector: 2.24 Industry: 3.67

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

174.65%

Sector: -26.85% Industry: -6.37%

ROE

221.91%

Sector: -29.78% Industry: -13.85%

ROIC

Sector: -416.25% Industry: -13.45%

NET MARGIN

100.00%

Sector: -28.18% Industry: -25.29%

GROSS MARGIN

-23.75%

Sector: 44.12% Industry: 51.96%

OPERATING MARGIN

-100.00%

Sector: -24.30% Industry: -19.68%

P/EBITDA

0.51

Sector: -0.28 Industry: 6.55

P/EBIT

0.53

Sector: -2.49 Industry: 7.01

P/ASSET

1.06

Sector: 1.23 Industry: 1.30

BVPS

1.09

Sector: 3.37 Industry: 8.51

EPS

2.42

Sector: -0.89 Industry: -0.01

EQUITY RATIO

0.79

Sector: 0.43 Industry: 0.43

CAGR REVENUE 5 YEARS

-21.31%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF AcelRx Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ACRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	49.22	38.00	77.20%	0.57%	$ 906.25 B	30.99%
ISRG	74.77	12.05	16.12%	0.00%	$ 205.40 B	28.58%
TMO	32.95	4.23	12.84%	0.29%	$ 216.51 B	15.02%
SNY	10.77	1.50	13.90%	4.47%	$ 121.40 B	14.83%
MDT	27.28	0.00	0.00%	2.78%	$ 129.94 B	13.71%
NVS	17.68	5.69	32.16%	2.93%	$ 254.54 B	25.53%
ABT	16.07	4.38	27.26%	1.83%	$ 224.54 B	31.88%
CVS	204.64	1.31	0.64%	3.52%	$ 95.97 B	0.12%
GSK	13.26	4.55	34.29%	3.43%	$ 96.81 B	17.23%
BSX	51.76	0.00	0.00%	0.00%	$ 144.52 B	14.43%
TMDX	50.58	13.07	25.84%	0.00%	$ 4.64 B	16.20%
HCA	17.88	-52.52	-293.84%	0.58%	$ 113.40 B	8.53%
IDXX	55.60	36.59	65.81%	0.00%	$ 57.13 B	24.65%
INMD	6.07	1.39	22.89%	0.00%	$ 908.46 M	41.04%
DHR	45.92	3.15	6.86%	0.54%	$ 160.86 B	14.43%
RMD	26.05	6.12	23.49%	0.85%	$ 37.46 B	27.35%
FMS	16.64	0.83	5.00%	3.39%	$ 13.58 B	3.73%
PHG	114.23	2.07	1.81%	3.28%	$ 25.72 B	1.14%
SYK	47.25	6.38	13.51%	0.92%	$ 139.06 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ACRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY AcelRx Pharmaceuticals

AcelRx Pharmaceuticals Inc.

Average user rating I10

4.0 (6 people)

United States

20 years

Founded: 2005

2011

Time since IPO - 14 years

54

Employees

The Company AcelRx Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 24.63 Millions, having an equity of $ 18.31 Millions.

With a total of 54 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 1.63 Million, which generated a loss in the amount of $ 40.63 Millions.

As for its main indicators, the Company has a P/E ratio of 0.61, a P/BV ratio of 1.35 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ACRX.

Market cap

$ 24.63 Millions

Net worth

$ 18.31 Millions

US$ 18,307,000.00

Assets

$ 23.26 Millions

US$ 23,261,000.00

Total Shares Outstanding

16.76 Millions

16,758,000

Average Daily Trading Volume

$ -

US$ -

Sector

Health

Industry

Pharmaceutical Products

ACRX

ACRX revenue and profits

Financial Results ACRX

DRAG THE FRAME TO SEE MORE DATA

ACRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.42 67,75% (12M)

P/E

204.64

3.52%

ROE

0.64%

P/BV

1.31

CI - Cigna

$ 274.70 --0,12% (12M)

P/E

11.49

2.23%

ROE

14.63%

P/BV

1.68

CNC - Centene

$ 40.85 --31,25% (12M)

P/E

-3.56

0.00%

ROE

-25.12%

P/BV

0.89

HUM - Humana

$ 268.45 --0,35% (12M)

P/E

23.97

1.37%

ROE

6.95%

P/BV

1.67

SNY - Sanofi

$ 48.68 8,63% (12M)

P/E

10.77

4.47%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 484.77 58,11% (12M)

P/E

17.88

0.58%

ROE

-293.84%

P/BV

-52.52

LLY - Eli Lilly

$ 1,027.51 32,88% (12M)

P/E

49.22

0.57%

ROE

77.20%

P/BV

38.00